Abstract
C18H19FN2O3Sn, monoclinic, C2/c (no. 15), a = 27.1120(3) Å, b = 9.5721(1) Å, c = 13.3072(1) Å, β = 98.271(1)°, V = 3417.55(6) Å3, Z = 8, Rgt(F) = 0.016, wRref(F2) = 0.043, T = 100(2) K.
The asymmetric unit of the title crystal structure is shown in the figure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.
Crystal: | Yellow prism |
Size: | 0.14 × 0.11 × 0.08 mm |
Wavelength: | Cu Kα radiation (1.54178 Å) |
μ: | 121.7 cm−1 |
Diffractometer, scan mode: | XtaLAB Synergy, Dualflex, AtlasS2, ω scans |
2θmax, completeness: | 134.2°, >99% |
N(hkl)measured, N(hkl)unique, Rint: | 19108, 3054, 0.021 |
Criterion for Iobs, N(hkl)gt: | Iobs > 2 σ(Iobs), 2973 |
N(param)refined: | 257 |
Programs: | Oxford programs [1], SHELX [2, 3] , ORTEP [4] |
Atom | x | y | z | Uiso*/Ueq |
---|---|---|---|---|
Sn | 1.03593(2) | 0.18572(2) | 0.54436(2) | 0.01938(5) |
F1 | 1.23392(4) | 0.83093(11) | 0.76403(10) | 0.0307(3) |
O1 | 0.95968(4) | 0.11587(13) | 0.52846(10) | 0.0259(3) |
O2 | 1.09603(5) | 0.33896(13) | 0.57464(10) | 0.0246(3) |
O3a | 0.87769(16) | −0.0365(5) | 0.5139(3) | 0.0206(8) |
O3′a | 0.87368(17) | −0.0243(5) | 0.4702(3) | 0.0195(8) |
N1 | 1.00493(5) | 0.37540(15) | 0.60330(10) | 0.0174(3) |
N2 | 1.03850(5) | 0.48275(15) | 0.63577(11) | 0.0184(3) |
C1 | 0.91867(7) | 0.17438(18) | 0.55216(14) | 0.0192(4) |
C2 | 0.91703(7) | 0.30860(18) | 0.59516(13) | 0.0183(4) |
C3 | 0.87167(7) | 0.3645(2) | 0.61810(14) | 0.0249(4) |
H3 | 0.8713 | 0.4552 | 0.6470 | 0.030* |
C4 | 0.82829(7) | 0.2899(2) | 0.59934(15) | 0.0270(4) |
H4 | 0.7980 | 0.3282 | 0.6153 | 0.032* |
C5 | 0.82902(7) | 0.1569(2) | 0.55643(15) | 0.0254(4) |
H5 | 0.7989 | 0.1052 | 0.5427 | 0.030* |
C6 | 0.87269(7) | 0.0997(2) | 0.53373(15) | 0.0253(4) |
C7 | 0.95958(6) | 0.39878(19) | 0.61917(12) | 0.0184(3) |
H7 | 0.9538 | 0.4854 | 0.6502 | 0.022* |
C8 | 1.08356(7) | 0.45227(18) | 0.61761(12) | 0.0181(3) |
C9 | 1.12316(6) | 0.55560(18) | 0.65236(12) | 0.0174(3) |
C10 | 1.17296(7) | 0.52091(19) | 0.65213(14) | 0.0223(4) |
H10 | 1.1813 | 0.4331 | 0.6258 | 0.027* |
C11 | 1.21060(7) | 0.6129(2) | 0.68982(15) | 0.0251(4) |
H11 | 1.2447 | 0.5891 | 0.6904 | 0.030* |
C12 | 1.19717(7) | 0.73946(19) | 0.72642(14) | 0.0214(4) |
C13 | 1.14843(7) | 0.77872(19) | 0.72732(14) | 0.0213(4) |
H13 | 1.1405 | 0.8671 | 0.7533 | 0.026* |
C14 | 1.11134(7) | 0.68607(18) | 0.68941(14) | 0.0204(4) |
H14 | 1.0774 | 0.7113 | 0.6885 | 0.025* |
C15a | 0.83344(14) | −0.1226(4) | 0.5047(3) | 0.0213(8) |
H15Aa | 0.8140 | −0.0991 | 0.5599 | 0.026* |
H15Ba | 0.8433 | −0.2221 | 0.5122 | 0.026* |
C16a | 0.80136(19) | −0.1014(5) | 0.4034(3) | 0.0278(10) |
H16A | 0.7717 | −0.1608 | 0.3994 | 0.042* |
H16Ba | 0.8204 | −0.1265 | 0.3487 | 0.042* |
H16Ca | 0.7912 | −0.0033 | 0.3962 | 0.042* |
C15′a | 0.82725(16) | −0.0866(4) | 0.4251(3) | 0.0191(8) |
H15Ca | 0.8332 | −0.1421 | 0.3652 | 0.023* |
H15Da | 0.8034 | −0.0113 | 0.4010 | 0.023* |
C16′a | 0.80407(16) | −0.1798(4) | 0.4971(3) | 0.0242(8) |
H16Da | 0.7729 | −0.2192 | 0.4619 | 0.036* |
H16Ea | 0.7971 | −0.1250 | 0.5556 | 0.036* |
H16Fa | 0.8272 | −0.2557 | 0.5204 | 0.036* |
C17 | 1.03680(8) | 0.2026(2) | 0.38741(15) | 0.0264(4) |
H17A | 1.0291 | 0.1115 | 0.3553 | 0.040* |
aOccupancy: 0.5.
Source of materials
The N-(3-ethoxy-2-hydroxybenzylidene)-4-fluorobenzohydrazonic acid was prepared from the 1:1 molar reaction of 4-fluorobenzoic hydrazide (Aldrich; 0.15 g, 1 mmol) with 3-ethoxysalicylaldehyde (Aldrich; 0.17 g, 1 mmol) in methanol (25 mL) solution. The obtained acid was purified and used in the preparation of the title compound. Triethylamine (Merck; 0.14 mL, 1 mmol) was added to a methanol solution (5 mL) of the acid prepared above (0.30 g, 1 mmol) and stirred. After 0.5 h, dimethyltin dichloride (TCI; 0.22 g, 1 mmol) was added to the mixture. The mixture was refluxed for 3 h. Yellow precipitates were obtained upon slow evaporation. The precipitate was washed with hexane and recrystallized from ethanol solution. Yellow crystals were obtained from the slow evaporation of this solution. Yield: 62%; M.p.: 438–439 K. IR (ATR, cm−1): 1650, 1606, 1573 (s, C=N–N=C), 590 (w, Sn–O), 461 (w, Sn–N). 1H NMR (in CDCl3): 0.83 (s, 6H, Sn–CH3), 1.45–1.52 (m, 3H, −OCH2CH3), 4.16–4.27 (m, 2H, −OCH2CH3), 6.62–6.72 (m, 1H, aromatic H), 6.82–7.16 (m, 4H, aromatic H), 8.06–8.20 (m, 2H, aromatic H), 8.68 (s, 1H, HC=N).
Experimental details
The C-bound H atoms were geometrically placed (C–H = 0.95–0.99 Å) and refined as riding with Uiso(H) = 1.2–1.5Ueq(C). The ethoxy group was found to be disordered over two positions. Refinement revealed the major component had a site occupancy factor = 0.505(8). Thus the occupancies of the disordered atoms were fixed at 0.5.
Discussion
Metal complexes of the hydrazone ligand [5], including those of organotin [6, 7] , are known to exhibit encouraging anti-microbial and anti-tumour potential. In continuation of related structural studies, the title compound has been structurally characterised and compared with its diphenyltin analogue [8].
The title structure is shown in the figure (70% displacement ellipsoids; one component of the disordered ethoxy group is shown with open bonds). The tin(IV) centre is five-coordinate within a C2NO2 donor set derived from N,O,O atoms of the dinegative, tridentate ligand and two methyl-C atoms.
Compared to the ideal τ values of 0.0 for an ideal square-pyramid and 1.0 for an ideal trigonal-bipyramid [9], the value of τ = 0.13 is indicative of a square-pyramidal geometry. In this description, the O1, O2, C17 and C18 atoms define the basal plane and the N1 atom occupies the apical position. The r.m.s. deviations of the four atoms defining the basal plane is 0.53 Å and their deviations are great at 0.5172(9), 0.5424(10), −0.5418(10) and −0.5179(10) Å, respectively. The tin atom lies 0.0598(8) Å out of the plane in the direction of the N1 atom. As expected, the widest angles subtended at the tin atom are in the basal plane, i.e. O1–Sn–O2 of 154.91(5)° and C17–Sn–C18 of 147.23(8)°.
As a result of the N,O,O coordination mode of the Schiff base dianion, both five- and six-membered chelate rings are formed. Both rings are planar with r.m.s. deviations of 0.0327 Å for the Sn,O2,N1,N2,C8 chelate ring and 0.0160 Å for the Sn,O1,N1,C1,C2,C7 chelate. The rings form a dihedral angle of 1.97(5)°. Indeed, the C7N2O2Sn atoms of all but the 4-fluorophenyl ring of the Schiff base ligand are coplanar, exhibiting a r.m.s. deviation of 0.0272 Å; the 4-fluorophenyl ring is slightly twisted out of this plane, forming a dihedral angle of 9.30(6)°.
The most closely related structure available for comparison is the recently described diphenyl analogue [8]. Here, the coordination geometry is almost exactly intermediate between the ideal extremes with τ = 0.43. The difference between the structures is readily rationalised in terms of steric effects. With smaller tin-bound methyl groups, centrosymmetrically related molecules in the title crystal can approach each other via secondary Sn⋯O bonding interactions [10] to form a dinuclear aggregate. Thus, the Sn⋯O11, O3i and O3′i separations are 3.0529(13), 2.941(4) and 2.927(5) Å, respectively, for symmetry operation i: 2 − x, −y, 1 − z. No such interactions are apparent in the diphenyltin analogue owing to steric congestion.
Acknowledgements
Sunway University is thanked for support of biological studies of tin Schiff base complexes.
References
Rigaku/Oxford Diffraction. CrysAlisPro. Rigaku Corporation, The Woodlands, TX, USA (2017).Search in Google Scholar
Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar PubMed
Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Search in Google Scholar PubMed PubMed Central
Farrugia, L. J.: WinGX and ORTEP for Windows: an update. J. Appl. Cryst. 45 (2012) 849–854.10.1107/S0021889812029111Search in Google Scholar
Banerjee, S.; Mondal, S.; Chakraborty, W.; Sen, S.; Gachhui, R.; Butcher, R. J.; Slawin, A. M. Z.; Mandal, C.; Mitra, S.: Syntheses, X-ray crystal structures, DNA binding, oxidative cleavage activities and antimicrobial studies of two Cu(II) hydrazone complexes. Polyhedron 28 (2009) 2785–2793.10.1016/j.poly.2009.05.071Search in Google Scholar
Hong, M.; Niu, M.; Wang, F.; Li, D.; Liu, J.; Yin, H.: Organotin(IV) complexes derived from Schiff base N′-[(1E)-(2-hydroxy-3-methoxyphenyl)methylidene]-pyridine-4-carbohydrazone: Synthesis, in vitro cytotoxicities and DNA/BSA interaction. Eur. J. Med. Chem. 86 (2014) 550–561.10.1016/j.ejmech.2014.08.070Search in Google Scholar PubMed
Lee, S. M.; Mohd Ali, H.; Sim, K. S.; Abdul Malek, S. N.; Lo, K. M.: Synthesis, characterization and biological activity of diorganotin complexes with ONO terdentate Schiff base. Inorg. Chim. Acta 406 (2013) 272–278.10.1016/j.ica.2013.04.036Search in Google Scholar
Tan, Y. S.; Lee, S. M.; Tiekink, E. R. T.: Crystal structure of (N-(3-ethoxy-2-oxidobenzylidene)-4-fluorobenzohydrazonato-κ3N,O,O′)-diphenyltin(IV), C28H23FN2O3Sn. Z. Kristallogr. − NCS 233 (2018) 331–333.10.1515/ncrs-2017-0416Search in Google Scholar
Addison, A. W.; Rao, T. N.; Reedijk, J.; van Rijn, J.; Verschoor, G. C.: Synthesis, structure, and spectroscopic properties of copper(II) compounds containing nitrogen-sulphur donor ligands; the crystal and molecular structure of aqua[1,7-bis(N-methylbenzimidazol-2′-yl)-2,6-dithiaheptane]-copper(II) perchlorate. J. Chem. Soc. Dalton Trans. (1984) 1349–1356.10.1039/DT9840001349Search in Google Scholar
Tiekink, E. R. T.: Supramolecular assembly based on “emerging” intermolecular interactions of particular interest to coordination chemists. Coord. Chem. Rev. 345 (2017) 209–228.10.1016/j.ccr.2017.01.009Search in Google Scholar
©2018 See Mun Lee et al., published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.